Foundation Medicine

Foundation Medicine is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient's unique cancer. The company's clinical assays, FoundationOne for solid tumors and FoundationOne Heme for hematologic malignancies and sarcomas, provide a comprehensive genomic profile to identify the molecular alterations in a patient's cancer and match them with relevant targeted therapies and clinical trials. Foundation Medicine's molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer.
Company Growth (employees)
Cambridge, US
Size (employees)
535 (est)
Foundation Medicine was founded in 2010 and is headquartered in Cambridge, US

Key People/Management at Foundation Medicine

Michael J. Pellini

Michael J. Pellini

President & CEO & Board Director
Steven J. Kafka

Steven J. Kafka

Chief Business Officer
Alexis Borisy

Alexis Borisy

Co - Founder & Chairman of the Board
Vincent A. Miller

Vincent A. Miller

SVP, Clinical Development

Foundation Medicine Office Locations

Foundation Medicine has an office in Cambridge
Cambridge, US (HQ)
150 Second St
Show all (1)

Foundation Medicine Financials and Metrics

Foundation Medicine Financials

Foundation Medicine's revenue was reported to be $116.9 m in FY, 2016

Revenue (Q3, 2017)

22.8 m

Net income (Q3, 2017)

(32.6 m)

EBIT (Q3, 2017)

(32.4 m)

Market capitalization (22-Dec-2017)

2.4 b

Cash (30-Sep-2017)

76.8 m
Foundation Medicine's current market capitalization is $2.4 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016


29 m61.1 m93.2 m116.9 m

Revenue growth, %


Cost of goods sold

11.7 m27.4 m36.7 m53 m

Gross profit

17.3 m33.6 m56.5 m63.9 m
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017


11.5 m14.5 m16.4 m19.3 m18.3 m21 m17.4 m20.7 m16.3 m16.7 m24.8 m22.8 m

Cost of goods sold

5.3 m6.6 m7.5 m8.9 m9 m9.1 m10 m11.5 m14.7 m17.1 m

Gross profit

6.2 m7.9 m8.9 m10.4 m9.4 m11.9 m7.4 m9.2 m1.6 m(436 k)

Gross profit Margin, %

USDFY, 2013FY, 2014FY, 2015FY, 2016


124.3 m72.1 m117.8 m63.6 m

Accounts Receivable

6.3 m9.9 m7.4 m8.2 m


992 k2.9 m6.5 m10.4 m

Current Assets

133.3 m89.6 m229.6 m168.9 m
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017


110.3 m97.1 m86.7 m61.7 m263.6 m250.2 m86.1 m62.3 m77.8 m49.1 m36.5 m76.8 m

Accounts Receivable

8 m6.1 m6 m10.7 m5.9 m13.6 m13.3 m


3 m2.6 m4.2 m4.5 m6.1 m9.5 m6.7 m10.2 m12 m10.3 m8.9 m10.4 m

Current Assets

122.5 m106.9 m98.3 m80.8 m289.5 m275.8 m235.9 m216.8 m196.5 m125.5 m103.3 m107.3 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(42.9 m)(52.2 m)(89.6 m)(113.2 m)

Depreciation and Amortization

5 m8.2 m10.6 m15.9 m

Accounts Receivable

(4.1 m)(3.6 m)2.4 m(844 k)


(442 k)(1.9 m)(3.7 m)(2.4 m)
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(12.2 m)(13.8 m)(13 m)(17 m)(33.1 m)(20.6 m)(17.3 m)(29 m)(31.3 m)(46.5 m)

Accounts Receivable

4.4 m6.1 m6 m10.7 m5.9 m


942 k2.6 m4.2 m4.5 m6.1 m9.5 m6.7 m10.2 m12 m10.3 m

Accounts Payable

3.3 m5.5 m5.5 m9.4 m9.4 m12 m8.5 m10.8 m12 m10.4 m
USDY, 2017


42.5 k

Financial Leverage

2.4 x
Show all financial metrics

Foundation Medicine Operating Metrics

Foundation Medicine's Customers was reported to be 30 in FY, 2016
FY, 2016






Show all operating metrics

Foundation Medicine Market Value History

Foundation Medicine Revenue Breakdown

Foundation Medicine Median Salaries

Source: 15 public H-1B filings from Foundation Medicine

Foundation Medicine's Web-traffic and Trends

Foundation Medicine Online and Social Media Presence

Foundation Medicine Company Life and Culture

You may also be interested in